PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC

Clinical trial NCT03829007 · COMPLETED

Trial details

NCT number: NCT03829007
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2019-04-15
Primary completion: 2020-12-17
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.